Latest / The Cancer Secrets Podcast / CSP S7EO94 - Ep.94, Integrative Oncology Breakthroughs: Hyperthermia and New Hope in Advanced Cancer Care
Transcript
- 0:07Hi, and welcome to the Cancer Secrets podcast. I am your Host and guide,
- 0:10Dr. Jonathan Stegall. Cancer is like a thief who
- 0:14has come to steal, kill, and destroy. I have personally seen
- 0:18it wreak its havoc on patients, friends, and even my own family.
- 0:22But I am on a mission to change the cancer paradigm through the practice of
- 0:26integrative oncology cancer treatment that integrates the best of
- 0:29conventional medicine with the best of alternative therapies. Backed
- 0:33by science and personalized to each patient. You
- 0:37need a positive voice you can trust. This podcast will share valuable
- 0:40information to give you practical hope for a better outcome.
- 0:44So I invite you to join me on this journey as we seek to change
- 0:47the cancer paradigm together. Hello and
- 0:51welcome back to the Cancer Secrets podcast. I'm your host, Dr. Jonathan Stegall,
- 0:55and this is season seven and episode number 94. And today we
- 0:59have a very special guest joining us, Rebecca Steele.
- 1:03Rebecca is a nurse practitioner who obtained her bachelor's degree in
- 1:06English and history, Illinois Wesleyan University in Bloomington,
- 1:10Illinois. And she subsequently obtained her Bachelor of Science in Nursing
- 1:13through Loyola University's accelerated Bachelor of Science in Nursing
- 1:17program. And she completed her Master's of Science in Nursing through Loyola
- 1:21University's Adult Gerontology Primary Care Nurse Practitioner Program
- 1:25with a specialization in oncology. She is a member of the Oncology Nursing
- 1:29Society as well as the American Holistic Nursing Society.
- 1:33Rebecca, such an honor to have you here. Yeah, thank you for having me. Thank
- 1:36you. My pleasure. Yeah, I'm excited to have you here, not only because
- 1:40you're a leader in the field of integrative oncology, but also because we're both passionate
- 1:44about using hyperthermia for cancer treatment. And so, you
- 1:48know, as a lot of our listeners may know, we did do an episode on
- 1:50hyperthermia to introduce the concept a number of episodes back. But
- 1:54today I'm excited because we can kind of dive deep. You've compiled some really great
- 1:58case studies. We've had some fantastic results, which I'm
- 2:01incredibly pleased with. Yeah, yeah. And you're a big believer, as I am,
- 2:05in using it for cancer treatment. So I'd like to kind of start, if I
- 2:09may, by. By learning about a little bit about you and how sort of you
- 2:12got integrate. Interested in integrative oncology for sure. Yeah. Yeah. I
- 2:15mean, I. I started off in teaching because I
- 2:19liked English and history, but. But then with teaching,
- 2:23you work with kids. And so I, various ways, ended up started
- 2:26working with my dad, who is a medical doctor, and
- 2:30he started his own practice in 1999. His passion was
- 2:34always sort of Integrative, or at one point was called sort
- 2:38of alternative medicine. He had a sister with schizophrenia. And
- 2:42so he kind of went off to learning about how do you best manage
- 2:45that. So then became schooled through, through
- 2:49life experience then in this concept of what we now
- 2:53call integrative or functional medicine. And it's always been his passion.
- 2:57And so I started working with him in 2005 because I wasn't doing
- 3:00much else. And it was fantastic. You know, I must say, most of
- 3:04what I learn about integrative cancer care and integrative oncology I
- 3:08learned from my patients because they are the ones and their family
- 3:12because they're the ones who by necessity have to
- 3:15figure things out and find pathways where we
- 3:19don't have established pathways in terms of standard
- 3:22oncology. Standard oncology has made leaps and bounds
- 3:26in terms of success, in terms of getting better and better
- 3:29outcomes for patients. But there's still some pretty significant
- 3:33gaps that. And there's just not necessarily the
- 3:37push from pharmaceutical companies which are, you know,
- 3:40drive a lot of oncology research. Use drugs if they're going to
- 3:44help, but just drugs. If we, if we could have cured cancer with drugs
- 3:48alone, then we would have already done that and it hasn't happened.
- 3:51And it's up to people whose loved ones are dealing with being
- 3:55told that there's nothing more we can do for you or we can't cure you.
- 3:58We're going to keep you comfortable for as long as we can. And that's not
- 4:01very inspiring to people. So it's. I learned from my patients and
- 4:04I, you know, my commitment to the field certainly is
- 4:08ongoing because of who I see in, in my practice.
- 4:12I love that. And I think it really sort of underscores to this,
- 4:16you know, the fact that patients are so empowered today. Right. I mean, in the
- 4:19old days, you know, patients had to basically go to their doctor and I guess
- 4:22they're really enterprising. They could go to a medical library and maybe look up some
- 4:25things. But these days with the Internet and, and access to all the
- 4:29same journals that we read and all those things, I mean, patients are so knowledgeable
- 4:32today. Yeah. And social media people are talking to each other and sharing experience.
- 4:36Experiences. And you know, I've heard the term grassroots oncology. I mean, I
- 4:40think a lot it is, it's not a top down, this is coming from the
- 4:43bottom up and from a much broader base of experience and,
- 4:47and, and knowledge. Right. Truly we can accomplish things with a team
- 4:50approach today. Right. With, with patient is an important part of that. Team. Teamwork
- 4:54makes the dream work. Yep, that's right. That's right. I love that.
- 4:58So you, you've had a lot of great exposure to integrative cancer treatment.
- 5:02Talk about hyperthermia, specifically. How did you sort of learn about hyperthermia and
- 5:06oncology and how have you sort of been using that? Yeah, yeah. So I,
- 5:09I first, I'd known about it, my first came across
- 5:13there's a naturopath up in Canada who got a device called
- 5:17Oncotherm. And then there's another practice that does IPT
- 5:21in Istanbul in Turkey. And in 2015 we do have
- 5:24an, you know, yearly IPT conference. And so we went to Istanbul, I
- 5:28believe it was 2014 or 2015. So the practice was started by
- 5:32an oncologist who he, at the time, he was probably 80,
- 5:3685 years old. His whole career he practiced
- 5:39standard oncology, even taught it. And just
- 5:44towards the end of his career, he couldn't believe that there just weren't many significant
- 5:48changes that have been made since he first became an oncologist, you
- 5:52know, 50 years before. And so he really made
- 5:55it a commitment, personal commitment to then how can I do better?
- 6:00And so he learned about ABT and then started providing
- 6:03that at his own practice and combining it with a particular device called
- 6:07oncotherm, which I don't believe there are any units here in the United States
- 6:10outside of clinical trial settings. But at the conference they basically
- 6:14been. It was case after case after case. The presentation was
- 6:18with all these case studies of people with metastatic disease looking at PET
- 6:21scan images where people were sort of lit up like Christmas trees. And
- 6:25then after a course of ipt, they also integrate ketogenic
- 6:29diet to a greater or lesser extent. They're also integrating the, the
- 6:33hyperthermia. They do intravenous high dose vitamin C. So there's, there's other things,
- 6:36supportive things that they're doing as well, but just so many cases of
- 6:40people who are basically in free and clear. Ned,
- 6:44as I like to call it, Ned is our best friend. No evidence of disease.
- 6:48And so I, we've always gotten really great results with
- 6:51ipt, but I just, there's, there's always room for, you know, what
- 6:55else can we do? And, and then I, but because
- 6:59we couldn't get the particular unit here in the States,
- 7:02then just really didn't pursue it until we came across a
- 7:06device called Thermofield, which is a local regional
- 7:10hyperthermia unit. And so a naturopath who
- 7:13I work with, Michael Robinson, who's just down the street from us In. In
- 7:17a town called Darien, he got a unit. And so we were doing IPT
- 7:21here, and then we'd send people over, they drive 15 minutes to his practice and
- 7:25then get the hyperthermia. And I just noticed that liver
- 7:28metastases were going away, getting smaller just
- 7:32fairly quickly. Same thing with breast masses, but
- 7:35tumors that can be problematic were
- 7:39just sort of melting away. And I would
- 7:43say at a quicker rate than if we were. We're only doing something
- 7:46systemic. So it's just. It's that concept of combining. You're treating
- 7:50local. What's going on locally, meaning in that area,
- 7:54the tumors in the breast, you treat that. If the tumors in the liver, you
- 7:56treat that, and then combining it with systemic. And for systemic,
- 8:01we do IPT or insulin potentiation therapy with the fractionated low
- 8:05dose chemotherapy. And so then we got a unit ourselves in
- 8:09December of last year, I believe. And I've just been
- 8:13really pleased with the results ever since. Yeah,
- 8:16and I agree. I've. I've seen the same. I've been using mine for a few
- 8:19years now, and. Same thing. I mean, definitely, you see, saw great results
- 8:24before that, but definitely accelerated those good things we were
- 8:27seeing. Um, and. And just for new listeners maybe, who haven't listened to me,
- 8:31typically in each episode, I typically at some point mention ipt,
- 8:34insulin potentiation therapy, as well as, of course, low dose or fractionated dose
- 8:38chemotherapy. But, you know, we're talking about combining those, right? And how impactful
- 8:42those can be together. They do work synergistically, for sure. For sure. They
- 8:46absolutely do. Well, Rebecca, if it's okay, I'd love to sort of dive into
- 8:49some case studies of yours. I mean, you. You've done an amazing job compiling some
- 8:53of these case studies, sort of what you've seen in your clinical practice. So if
- 8:57it's okay, I'd like to sort of dive into some of those. Would that be
- 8:59okay? Absolutely, yeah. So our first case is
- 9:03a. A patient who had an aggressive
- 9:06cholangiocarcinoma, sort of that gallbladder, that bile
- 9:10duct area they had. The diagnosis of cholangiocarcinoma
- 9:14was made. They had obstructive jaundice, so they had a blockage in their liver. They
- 9:17were they yellow skin, yellow eyes. They were found on imaging to
- 9:21have numerous areas of cancer involvement in the
- 9:25liver, both lobes of the liver, as well as some other areas
- 9:28sort of in the abdomen, what we call retroperitoneal. So that patient had undergone,
- 9:32I'm assuming this was prior to you, they'd undergone a robotic Cholecysectomy, they
- 9:36took out the gallbladder surgically. They had a stent place to
- 9:40sort of, you know, help. Help things fall a little bit better. And then again,
- 9:43more imaging showed that they had widespread cancer. And then they.
- 9:47The tumor marker we typically use, called a CA19.9,
- 9:51that was over 10,000 and normal range goes up to about 35 or 40.
- 9:54So very, very high cancer activity based on all those
- 9:58findings. And so then after that, I believe you inherited the patient
- 10:02and you started doing your normal treatments with lymph, low dose chemo,
- 10:05ipt, things like that. We did, yeah. Yeah. And, you know,
- 10:09I just want to say too, like, basically when somebody's
- 10:13bilirubin is that elevated and when there's
- 10:16liver function as well is compromised, then they're not really
- 10:20candidates for what's available in terms of the standard of care. There's a lot of
- 10:24oncologists who would have some deep hesitations about treating because
- 10:27they could make things much worse. It increases the risk for infection
- 10:31and which could then spread. Um, so out of a
- 10:35caution of possibly hastening somebody's death, then somebody in
- 10:39a situation like this is. They're not necessarily a
- 10:42candidate for any sort of standard therapies at this point. And so we started
- 10:46treating her. It was about. It was a year ago, so it was March of
- 10:49last year. And like I said, I mean, it could have been the end of
- 10:52the road for her a year ago. Right. And instead she's doing really well
- 10:56and she's living her life and she's had all this time with her family and
- 11:00her grandchildren and. And I was surprised too. I mean, I was pleasantly
- 11:03surprised, but I was. I was, you know, kind of amazed as well. Not that
- 11:07I didn't know what sort of expectations to have, but basically the.
- 11:11The jaundice cleared up and her pain and discomfort that
- 11:15she was having no longer needed medications to manage that.
- 11:18And, you know, there's still the challenge of, you know, logistics and
- 11:22travel. She doesn't live in the area, so. But she. We have
- 11:25to a certain extent coordinated with, with practitioners back where she lives then,
- 11:29um, so that she could do things at home. So there's still always that challenge
- 11:33with metastatic disease where it just. You. You have to
- 11:37mix things up, you have to try everything you can. But I, like I said,
- 11:40I was very amazed and very pleased. And I do think
- 11:44that the addition of the hyperthermia, which we put right over the liver
- 11:48then, really made a big difference in turning it around basically
- 11:51within the first week or two Within a week, we usually
- 11:55do two treatments a week and within a week her bilirubin had
- 11:59hugely dropped. No, the symptoms of itchiness and abdominal pain
- 12:03were already better. And just the hyperthermia
- 12:07in a number of different ways then just really works in a
- 12:10beautiful way to synergize with what we're doing systemically. So what
- 12:14we put into the bloodstream and get circulating with the ibt.
- 12:18So heat then dilates blood vessels, brings
- 12:21blood flow to a specific area. So if you're heating the area
- 12:25in the liver, then we are increasing then the, the, the
- 12:29delivery of whatever we have on board circulating systemically. So
- 12:33we obviously with IBT we're, we're using chemotherapy. We also
- 12:36sometimes will follow that up with, with quercetin, which has some
- 12:40chemosensitizing effects, has some additional anti cancer benefits.
- 12:44Sometimes we, we combine it with curcumin, which likewise has some anti
- 12:47inflammatory anti cancer benefits. But once again it's all synergized by the
- 12:51fact that we're combining it with the local regional hyperthermia to
- 12:54help deliver whatever we have systemically circulating to that
- 12:58specific area. And, but it was just, it was really
- 13:02phenomenal. And, and she's, she's still going strong. So.
- 13:05And that, that turnaround though was, was kind of amazing. And then she was in
- 13:09a place where there, there weren't really any other options
- 13:13other than proceeding with hospice care. So. Right. And the, in the,
- 13:17and the improvement was dramatic. I mean the, the CA99 marker came
- 13:20down under a thousand. It came down to over 90%. Right.
- 13:24Reduction symptoms got better, obviously. Exactly. Yeah.
- 13:28So the, so the cancer, she was longer, yellow, didn't have the neon yellow
- 13:31eyes. Yeah, right. Yeah. That's amazing. And just
- 13:35to know, I mean one thing I know you, you've noticed as well about the.
- 13:38So we use the hyperthermia device of course, called Thermofield. And the nice thing about
- 13:41it is it's so well tolerated because some of the older machines you risk
- 13:45burning the patient's skin. These were big, bulky machines, you know, very,
- 13:49very cumbersome in an office setting. And the nice thing about the hyperthermia is it's
- 13:52very portable, it's small, but you know, the ability to really put
- 13:56that treatment pad over the area we want to target. So you know, it's
- 14:00a, I don't know the exact measurements, but it's probably about what, six by six
- 14:03or six by. Yeah, yeah, yeah. So it's not a huge
- 14:06applicator, but it's nice because it just sits on the skin, but then the heat
- 14:09collects underneath. And so, you know, being able to, to collect the heat where
- 14:13we want it versus the heat intensity being primarily on the skin makes a
- 14:17big difference, right? Yes. Yeah. The oncotherm uses radio
- 14:20frequencies to transmit that heat and heat the tissue
- 14:24about 6 centimeters from the skin. But no, we, we. It's
- 14:27incredibly well tolerated and, and the risks are, are
- 14:31pretty nil in terms of side effects or, or,
- 14:35or risks involved in it is pretty safe, which is, and, and
- 14:38it enhances whatever else you're doing by leaps and bounds. So it's. Right.
- 14:42Very helpful. Absolutely. And then the next case I wanted to discuss was a
- 14:46breast cancer patient. This was A young woman, 32 years old,
- 14:50hormone negative. Her two positive breast cancer came to you
- 14:54with widely metastatic disease. Cancer had, you know, stage four, had spread
- 14:57to the bone, liver, and eventually brain. And as
- 15:01expected, her lab markers, her tumor markers were very elevated as
- 15:05well. CA 15, 3 and CA 27, 29. And
- 15:08you had noted in your, in your write up that she. The spinal metastases to
- 15:12the bone and the spine were very severe. They'd compressed some
- 15:16of the vertebra, especially the lower back, the lumbar area. And then. So
- 15:20you started treating her. I believe it was February of last year. Yeah, it might
- 15:23even have been. Let me just double check. It might have been.
- 15:27Let's see, it was 2020. Yeah, 24. I'm sorry, 24.
- 15:31Yeah. Yeah. We are in 2026, aren't we? Yeah, yeah.
- 15:35She's, I mean, like I said it. That's. Once again, she was in a case
- 15:38where, you know, they were discussing hospice and she's 32 and
- 15:42she has three beautiful, adorable children. And
- 15:46but, you know, they'd even, what they did was they put in basically
- 15:50a permanent pain pump because that those compression fractures of the
- 15:53lumbar spine were affecting not only the level of just,
- 15:57you know, pain in her, in her body, but then also her muscle function. So
- 16:01she was having a lot of difficulty walking. We do
- 16:04also, we're very lucky to work with a local interventional
- 16:08radiologist who likewise, once again focusing on, you
- 16:12know, combining local treatments with systemic therapy. He
- 16:16does a number of, he does radio frequency ablation. He also
- 16:20does kyphoplasty, where he's basically cementing any sort
- 16:23of pathologic fractures in place. You use a balloon to increase that vertebral height,
- 16:27relieve the pressure on the nerves, and then you cement it in place to stabilize
- 16:31it. And so that made a huge difference too at
- 16:35the outset. And, but I want to say it was within a month she
- 16:38stopped using that implanted pain pump. She didn't have to put the
- 16:42morphine in it anymore. And we treat it, we use. And then this
- 16:46is the versatility of the hyperthermia. We, you can rotate
- 16:49the, the sites we were. She did have liver metastases which have
- 16:53not shown up on the last two scans. Those, those have not. Those are,
- 16:57those have been gone. We also then have used it to treat the
- 17:00specific areas in her spine as well as, as
- 17:04her scapula. But there's. So she's got widespread metastatic
- 17:08disease in the, in the bone. But the beauty of the hyperthermia is that we
- 17:11can treat that area and sometimes even the same day, then it will
- 17:14relieve, if she's having pain in that area, it'll relieve the pain once again. It's
- 17:18bringing blood flow which brings oxygenation, carries away metabolic
- 17:22waste. And then of course, whatever else we have on board systemically circulating
- 17:25to treat the cancer directly. Then there's still always
- 17:29scarring that shows up on the scans, but there's no new spots showing up. Nothing
- 17:33is worsening and she's able to function and,
- 17:37and at the same time and, and be out of that pain that she
- 17:40was in. Right, Excellent. And then our next case
- 17:44is a middle aged man, 44 years old. He was
- 17:48diagnosed with colon cancer. He was diagnosed in May of
- 17:512022 with a stage 3 rectal
- 17:55cancer. Some lymph nodes in that area were also positive for
- 17:58cancer. And then he had a recurrence in 2023
- 18:03involving the Lung and the brain. It sounds like By January of
- 18:062024 he had a new lesion in the lumbar
- 18:10spine as well. So he had widely metastatic disease before he met you.
- 18:13I believe he had had the surgery and it sounds like maybe
- 18:17some mainstream treatment with sort of full dose chemo and some radiation.
- 18:21Does that sound right? Yeah. But this particular patient then, you know, is
- 18:25a case of what we call early onset colorectal cancer.
- 18:28And early onset colorectal cancer is a growing problem
- 18:32not just in this country, but I believe world, and
- 18:36even went so far. So the United States Preventative Task Force then,
- 18:40which doesn't oftentimes make changes so far as screening
- 18:43recommendations, but they did make a screening recommendation change
- 18:47then to start colonoscopies at age 45 versus
- 18:5150. And it takes a lot, leaves a lot of data. It takes a lot
- 18:54of long term data for them to make any sort of changes like that, especially
- 18:58one so significant. But unfortunately she missed the, the
- 19:02cutoff anyway, because then they, they were 44
- 19:05at diagnosis. So when they first came for
- 19:09treatment here, then we just, we did discover for the first
- 19:13time that there was a lesion to the lumbar spine. And
- 19:17then, so we were able to treat that in combination with the ibt
- 19:20and then with the addition of the local regional hyperthermia right to
- 19:24that area in the lumbar spine, got significant reduction in terms
- 19:28of cancer activity, which then once again, we, you know,
- 19:31combining certain, sometimes with, with metastatic disease,
- 19:35then your best approach is a combination of different treatments.
- 19:38But I will say that being able to, to first treat with the
- 19:42hyperthermia, she did follow up with, with stereotactic
- 19:46radiation then to that area as well. But it, that area in
- 19:49the lumbar spine then was stable for about two years where
- 19:53nothing much changed. She did do additional systemic therapy at home,
- 19:57but really that, that area there was stable for about two
- 20:01years with a combination of the local regional hyperthermia plus the ivt.
- 20:05And then she did follow up with stereotactic radiation to that area.
- 20:09But for two years, no pain and no progression in that area,
- 20:12which then, especially for somebody who's, who's young and living
- 20:16their life, that's, that's huge. Right? Right,
- 20:19absolutely. And then the last patient I want to discuss with you,
- 20:23this was a gentleman with high grade prostate
- 20:27cancer. So this is a gentleman who was diagnosed with a Gleason
- 20:30of nine. And so for those who aren't familiar, the gleason is a way we
- 20:33sort of measure aggressiveness of prostate cancer. And so typically it goes up to
- 20:3710. And so a nine is a very aggressive cancer. So a Gleason, based on
- 20:41what they see on the pathology, showed an aggressive cancer show. He did
- 20:45have spread outside of his prostate to, you know, despite having
- 20:48the prostatectomy, the prostate removed, had some evidence of spread
- 20:52outside the prostate. His PSA was still elevated at that point,
- 20:56and he also had a, an elevated circulating tumor DNA
- 20:59level. Of course, one of the tests we can use to measure little fragments of
- 21:03cancer genetic material, and that was elevated. So he
- 21:06did have, sounds like some workup, including a PET
- 21:10scan and a nuclear bone scan, which did not show any obvious
- 21:14cancer anywhere. But we knew based on the PSA that he had some cancer
- 21:17somewhere. Right? Correct. Right, yes. And they knew based on the surgery
- 21:21that they, they did not get everything. The plan
- 21:25initially was to follow up with radiation to the area, which is
- 21:29not necessarily a desirable outcome either, simply because
- 21:32when you, when you radiate the pelvic area, then you can get scar
- 21:36tissue, and that can affect the function of the pelvic area, including
- 21:40sexual function, and then also bladder bowel function. So he did go
- 21:43consult with a radiation oncologist, but the radiation oncologist, you know,
- 21:47thankfully, was. Was fairly straightforward and just said that, you know, I might
- 21:51do more harm than good. I'm not gonna be able to get all this anyway,
- 21:54and so I'm not gonna expose you to it. So at that point, then he
- 21:57did come to see us. So we did. We did 12 sessions of IPT
- 22:01along with the local regional hyperthermia. And like I said, it's. It's very
- 22:04adaptable as to where you can place the pad. So to heat the pelvic area,
- 22:08we basically have somebody sit on it. So we call it the hot seat.
- 22:12And so. And it would. To evidently
- 22:16treat the, you know, what the. Where the prostate was, but then also
- 22:20the pelvic area. And his circulating tumor cell
- 22:23DNA, as well as his PSA level then kind of dropped like a stone.
- 22:27And this was now, once again, probably about a year
- 22:31out. And we do follow him monthly with that
- 22:34circulating tumor cell DNA test. And it's
- 22:38been zero as of the last two months. Then
- 22:42it was positive, but it went from zero to
- 22:450.05. In the last two months, it's been
- 22:480.05, which is. It's positive, considered positive,
- 22:52but pretty darn low. And there's a lot of other
- 22:56strategies that. That we could focus on to. To deal with that.
- 23:00But once again, like a case where the standard of care wasn't
- 23:03necessarily ideal. It was a patient whose situation
- 23:07kind of fit outside the range of what's easily,
- 23:10straightforwardly manageable with the standard of care. And that's just where.
- 23:14With what we have to innovate at that point. And
- 23:18I'm just very thankful that we have tools at our disposal that. That allow us
- 23:22to innovate and innovate in such a way where we can get really good results
- 23:25and at the same time, people can maintain and even
- 23:29improve their quality of life. It's very rewarding. Right, Right. And I
- 23:33always like to say selective use of our tools. Right. So you didn't. Didn't tell
- 23:36him he shouldn't have surgery or didn't tell him he can't use, you know, Lupron,
- 23:39which he's. I think he's on to help kind of maintain things, but. Right. Augment
- 23:43that with all the great things you're doing. Makes total sense. Yeah. And about three
- 23:46months ago, he did discontinue that because it made him really tired, which
- 23:50happens. And. But even then, he's maintained
- 23:54that circulating tumor cell level was. Was still remained zero. Now, like I said, it
- 23:58did go to an incredibly low positive. But that's sort of the dis. The
- 24:02sort of. You have the path that you have to take. There's not a
- 24:05straightforward path when there's not a straightforward cure. That's great.
- 24:09That's a good quote. I like that. So I think in looking back at all
- 24:12of these cases we kind of discussed today, I think the. The
- 24:15commonality really is that, you know, treatment was working
- 24:19regardless. But the addition of the hyperthermia really helped
- 24:22sort of tailor that treatment and focus that treatment in necessary areas. You know, in
- 24:26terms of. Locally. Yeah, it helps in multiple ways. Yeah. Both
- 24:30qualitatively and then in terms of quantitative, measurable
- 24:33benefit based on CT scans and then tumor markers, the blood tests that we
- 24:37do, that definitely both areas, then
- 24:40pretty significant and rapid improvement. Right.
- 24:44And you're also doing something that I, you know, I do as well, and that's
- 24:47just aggressively monitor treatment. Right. Because a lot.
- 24:51A lot of people will try to do treatments, and they think it's helping them
- 24:54because maybe they feel better or maybe they just have this belief that it's helping
- 24:57them, but they're not getting the appropriate testing. And as you and I know, there
- 25:01are certain clinics that don't do very good testing either. But to be able to
- 25:04truly measure the tumor markers and
- 25:07advanced testing like the circulating tumor DNA and the scans and all these
- 25:11things that, of course, no one wants to have to have, but to be able
- 25:15to give us that objective data of, wow, this treatment is really working
- 25:18well, that's so meaningful. Absolutely. Yeah. Yeah. I mean, I tell people
- 25:22I'm not attached to how we achieve our treatment goals. You know, I. I
- 25:26don't. I. It's hard to say, you know, if I were in this position, what
- 25:29would I do or not do? I don't know. And so we're not attached to
- 25:33how we achieve our treatment goals, but you have to be able to respond if
- 25:36something's not working or then you want to be able to respond. You want to
- 25:40be able to get that indication early on and then make what
- 25:43adjustments, make what. What changes that you need to do to get things turned around.
- 25:47And that's just where you. You have to use a combination of
- 25:51qualitative data. Yes. How are you feeling? How are your symptoms? We need to
- 25:55see those improve, obviously, but we. We do always have to keep an eye
- 25:58on. On those quantitative measures, the numbers, which is either blood
- 26:02tests or ultimately scans. We just got to get a picture and have little
- 26:06windows in our body. Right, Exactly. Well,
- 26:09so, Rebecca, if you could just share, you know, one piece of advice with our
- 26:13listeners in terms of sort of dealing with a cancer diagnosis, what would it
- 26:16be? Is it can be treatment, it can be testing, it can be
- 26:20mindset, whatever, whatever you want to. However you want to take it.
- 26:24Yeah, yeah. I mean, I, I just get as much information
- 26:27as you can. So then, you know, go into an information
- 26:31gathering, consult with an oncologist. They're, you know,
- 26:35oncologists are they. They go into the field because they want to help people.
- 26:38It's. But. And, and just with mainstream. You're saying a
- 26:42mainstream standard of care, Correct? Get their opinion. Yeah, correct. Yes. Yes.
- 26:46Then there are. Some of them are really good doctors on top of
- 26:50now. You know, are they always able to help everybody? They're. They're
- 26:54not by base. Whatever treatment decisions that you make,
- 26:57then basing on as much objective data and information
- 27:01as you can gather. And then I will. I also tell people too, you
- 27:04know, go with your gut. Right. I mean, we do have a gut sense. This
- 27:08is something that's evolved over the millennia in terms of human beings. We,
- 27:12we weren't always able to rely on data. We didn't have the
- 27:16Internet to look things up until very, very recently. But
- 27:19we nevertheless had to know how to stay safe, how to take care of our
- 27:23bodies in what historically has been a very
- 27:26harsh physical environment. And in that sense, we,
- 27:30we do have a gut sense. We still talk about it, but obviously
- 27:34sometimes our cognition is prioritized over that. But our gut sense, though,
- 27:37does help to guide us and keep us alive. And so
- 27:41it's. It's about combining that. If, if there is something, if a certain
- 27:45approach or you're being told that this, this is
- 27:49what you have to do, this is the only way forward then. But
- 27:52that just is not feeling that that's a possibility, then
- 27:56trust that sense and then once again go to the information
- 27:59gathering and information gathering activity and, and that's
- 28:03where friends and family, I think, do help a lot as well. I mean,
- 28:06obviously there can sort of be a certain background noise where, you know,
- 28:10somebody you just meet is like, oh, I did this once, or I heard about
- 28:13this once. And then that can be very overwhelming. But I do also tell people
- 28:17too, don't feel either that you have to do everything
- 28:21all at once or all at the same time. Everything that we put into
- 28:24our body, our body has to do something about and immune
- 28:28Function takes cell energy in order to. To work
- 28:31rep. Bodily repair takes cellular energy in order to happen.
- 28:36Tumor breakdown and basically eating up of tumor.
- 28:39That is our body that does that. It's not the medications, it's not the treatments.
- 28:44So much of the work of clearing out cancer then
- 28:48is our body and it's all energy dependent. So it's
- 28:52also about just being, being frugal with your resources, with your.
- 28:56Sometimes less is more in terms of treatment, prioritize.
- 29:00And then rest. That's deeply undervalued
- 29:03in medicine is the concept of rest. I
- 29:07read some stories as a, as a kid. It's also on.
- 29:11There's a PBS show called All Creatures Great and Small, which is based on
- 29:14a 1930s that in England, in Yorkshire. So he saw a lot of, a
- 29:18lot of farm animals and then when he retired wrote some really
- 29:22adorable stories about animals, but also about healing and the miracles of healing.
- 29:26So, you know, very feel good stories. One of my favorites. A lot of them
- 29:29are my favorite, but one of my favorites. Then he discusses a. A
- 29:33sheep who had a really difficult lambing. And sometimes they'll have three or four
- 29:36lambs at a time, which sounds terrifying as, as a woman, but
- 29:41so this, this sheep was sort of done in. The farmer called him and he
- 29:45said, you know, she's. She just not doing well and you're sort of lying in
- 29:48the barn, sides heaving in pain and distress and just basically
- 29:51on her way out. And so James, James,
- 29:55Harriet is his pen name, and gave her an overdose of
- 29:59barbiturates, which at the time was sort of how they put animals to sleep. And
- 30:02barbiturates are painkillers. So basically just got her out of
- 30:06pain with the intention then of, of, you know,
- 30:10putting her asleep. And she didn't die for a couple of days.
- 30:13She just kind of slept in the barn and when she came out of it,
- 30:17then she started nibbling some grass and started, you know, sniffing around
- 30:21for her lambs. And James, reflecting on it later on in
- 30:25his career then, you know, he, he just said of all the different innovations
- 30:28that he'd seen throughout his lifetime from the 1930s onward, from
- 30:32all the different medications and procedures, the best thing he could have done for that,
- 30:36for that patient was to get her out of pain, get her out of fear,
- 30:39and give her body the time and the space to do the repair work that
- 30:43it knows how to do. So that's. That. That too
- 30:47is, is just sort of an unacknowledged, not necessarily deeply
- 30:51honored concept in, in modern medicine, but it's, it's all
- 30:54about then setting up the healing environment to, for that, for
- 30:58that work to happen. And sometimes it just takes rest. And
- 31:02I love that. That's beautiful. Rebecca, how can our
- 31:06listeners learn more about you? So, you know, we, I, I
- 31:09do work in a practice here, sort of based on the one
- 31:13that my dad started in 1999 and I sort of carried on
- 31:17without really. That wasn't really my plan or my intention, but it's definitely become
- 31:21my passion since then. But yeah, we do have a website and you
- 31:25know, between the hours of 8 and 9 in the morning when I drive home
- 31:28and then between 4 and 5 Central when I, when I'm driving home, when I'm
- 31:31just sitting in the car listening to music anyway. So oftentimes that's the time when
- 31:35I just take the opportunity to talk to people. You know, growing up I,
- 31:38you know, as a teenager didn't quite like people. Maybe a lot of
- 31:42teenagers felt that way. But then I started talking to people and getting to know
- 31:45them and I'm like, people are pretty cool. I like people.
- 31:49So I'm more than happy. It's not really work, it's not my job when
- 31:53it, when you love doing it. And so I do just love to talk to
- 31:56people and get to know more about them. Um, but yeah, but we do have
- 31:59a practice here in the Chicago area in a southwest suburb called Bur Ridge.
- 32:03And we've got people who come from all over. Sometimes a lot all over the
- 32:06Midwest, sometimes from Canada. But then I'm also more than
- 32:10happy I, to refer to where people are
- 32:13elsewise and, and Dr. Stagall. I mean, I, if there's somebody
- 32:17who, or logistically it's, it's more convenient and it's more
- 32:21therapeutic for them to not have to travel, then I'm, I'm
- 32:24always more than pleased to be able to have a network of people to
- 32:28participate in care because I don't have all the answers. No one person ever
- 32:32does. And it takes teamwork. I'm more than happy to have
- 32:36someone like you on the team. Yeah, likewise, it takes, it takes a
- 32:39collaborative effort and those of us in our integrative
- 32:42oncology little niche have to stick together. So yes, yeah, yeah,
- 32:47I'm glad to get to make the connection. And yeah, this has
- 32:51been a great episode. Just thank you so much for your time. I know our
- 32:54listeners have really enjoyed it. Really. They're really going to get
- 32:58a lot out of this and so thank you so much for taking time out
- 33:00of your busy schedule to spend a little bit of it with us on the
- 33:03podcast. Yeah, my pleasure. Absolutely. Well, thank you. Well, to all our
- 33:07listeners, thank you again for listening. And stay in touch because we're going to
- 33:11have some more great content coming your way soon. But until next time, bye.
- 33:15Bye.
- 33:22Sa.